Compare RXT & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RXT | MLAB |
|---|---|---|
| Founded | 1998 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Industrial Machinery/Components |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 481.5M | 461.9M |
| IPO Year | 2020 | 1995 |
| Metric | RXT | MLAB |
|---|---|---|
| Price | $1.02 | $87.59 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 6 | 1 |
| Target Price | $1.71 | ★ $94.00 |
| AVG Volume (30 Days) | ★ 11.4M | 116.0K |
| Earning Date | 05-07-2026 | 02-03-2026 |
| Dividend Yield | N/A | ★ 0.75% |
| EPS Growth | 75.13 | ★ 99.24 |
| EPS | N/A | ★ 1.95 |
| Revenue | ★ $2,685,700,000.00 | N/A |
| Revenue This Year | N/A | $6.07 |
| Revenue Next Year | $1.35 | $5.41 |
| P/E Ratio | ★ N/A | $43.63 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.39 | $59.63 |
| 52 Week High | $2.74 | $128.55 |
| Indicator | RXT | MLAB |
|---|---|---|
| Relative Strength Index (RSI) | 35.96 | 56.30 |
| Support Level | $0.39 | $85.91 |
| Resistance Level | $1.22 | $89.69 |
| Average True Range (ATR) | 0.19 | 3.01 |
| MACD | -0.13 | 0.73 |
| Stochastic Oscillator | 6.07 | 92.66 |
Rackspace Technology Inc is an end-to-end, hybrid, multi-cloud technology services company. It designs, builds, and operates its customers' cloud environments across all technology platforms, irrespective of technology stack or deployment model. The company's solutions include Application Services, Data, Colocation, Cloud, Managed Hosting, Professional Services, and Security and Compliance. It has two reportable segments: Private Cloud and Public Cloud. Maximum revenue is generated from the Public Cloud segment, which offers cloud solutions through managed services, elastic engineering, and professional services offerings for customer environments hosted on the AWS, Microsoft Azure, and Google Cloud public cloud platforms. Geographically, the company derives its key revenue from the U.S.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.